Susan M Staugaitis

Clinically feasible MTR is sensitive to cortical demyelination in MS

Elizabeth Fisher, Douglas L Arnold, Robert J Fox, 2013, Neurology.

Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

Matthias Mack, Robert J Fox, Grahame Kidd, 2006, Brain : a journal of neurology.